Company intelligence / Profile preview

Opsonin Pharma Ltd.

Barisal Division / Dhaka Division, Bangladeshopsonin-pharma.com ↗

Ownership: Private
Employees: ~10000
Development stage: Commercial

Overview

Opsonin Pharma Ltd. manufactures and markets over 350 brands with more than 800 SKUs of pharmaceutical finished products. The company produces nearly all dosage forms and has been the first in Bangladesh to locally manufacture suppository formulations and third-generation antibiotics like ceftriaxone. Their products are distributed both domestically and internationally

Therapeutic areas: Other
Modalities: Small molecules (generic drugs)various dosage forms including tablets, capsules, powders for suspension, liquids, injections, infusions, oral liquids, semi-solids (creams/ointments), suppositories, sprays/inhalers (MDI/DPI)
Industry: Biotech

Partnerships

Not specifically disclosed.

Beyond the preview

Go deeper on Opsonin Pharma Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opsonin Pharma Ltd..

Explore the full profile